There was no association found in infants treated with erythromycin ophthalmic ointment. Erythromycin's widely known gastrokinetic properties have been suggested as the mechanism that causes this ...
Outlook Therapeutics' Lytenava has become the first ophthalmic formulation of VEGF inhibitor bevacizumab to be cleared for use by the NHS in England and Wales for treating wet age-related macular ...